Retraction
Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model”
Paper Information
Record ID:
26491
Author(s):
Journal:
Publication Date:
July 20, 2011
Retraction Date:
March 03, 2021
(4.7 years years ago)
Subjects:
Institutions:
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (12)
12
Total Citations1
Post-Retraction(8.3%)
11
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
1
After 2+ years
1099
Days since retraction (latest)
Novel LC-MS/MS Method for Simultaneous Determination of Monoamine Neurotransmitters and Metabolites in Human Samples
Dileshwar Kumar, Sukesh Narayan Sinha, Balaji Gouda
Journal of the American Society for Mass Spectrometry
Published: Mar 2024
11 citations
11 citations
1099 days after retraction
Parkinson’s disease managing reversible neurodegeneration
Marty Hinz, Alvin Stein, Ted Cole et al. (5 authors)
Neuropsychiatric Disease and Treatment
Open Access
Published: Apr 2016
3 citations
3 citations
1797 days before retraction
Parkinson's disease: carbidopa, nausea, and dyskinesia
Marty Hinz, Alvin Stein, Ted Cole
Clinical Pharmacology Advances and Applications
Open Access
Published: Nov 2014
12 citations
12 citations
2314 days before retraction
Management of L-dopa overdose in the competitive inhibition state
Marty Hinz, Alvin Stein, Ted Cole
Drug Healthcare and Patient Safety
Open Access
Published: Jul 2014
4 citations
4 citations
2437 days before retraction
Administration of supplemental L-tyrosine with phenelzine: a clinical literature review
Marty Hinz, Alvin Stein, Ted Cole et al. (4 authors)
Clinical Pharmacology Advances and Applications
Open Access
Published: Jul 2014
2437 days before retraction
Self-reported sleep disturbance is associated with lower CD4 count and 24-h urinary dopamine levels in ethnic minority women living with HIV
Julia Seay, Roger C. McIntosh, Erin M. Fekete et al. (7 authors)
Psychoneuroendocrinology
Open Access
Published: Jul 2013
64 citations
64 citations
2793 days before retraction
5-HTP efficacy and contraindications
Marty Hinz, Alvin Stein, Marty Hinz
Neuropsychiatric Disease and Treatment
Open Access
Published: Jul 2012
29 citations
29 citations
3167 days before retraction
Relative nutritional deficiencies associated with centrally acting monoamines
Marty Hinz, Alvin Stein, Thomas Uncini
International Journal of General Medicine
Open Access
Published: May 2012
11 citations
11 citations
3228 days before retraction
The discrediting of the monoamine hypothesis
Marty Hinz, Alvin Stein, Thomas Uncini
International Journal of General Medicine
Open Access
Published: Feb 2012
19 citations
19 citations
3318 days before retraction
Monoamine depletion by reuptake inhibitors
Marty Hinz, Alvin Stein, Thomas Uncini
Drug Healthcare and Patient Safety
Open Access
Published: Oct 2011
11 citations
11 citations
3441 days before retraction
APRESS: apical regulatory super system, serotonin, and dopamine interaction
Marty Hinz, Alvin Stein, Thomas Uncini
Neuropsychiatric Disease and Treatment
Open Access
Published: Aug 2011
14 citations
14 citations
3502 days before retraction
Paper citing Validity of Urinary Monoamine Assay Sales Under th...
Unknown Authors
Unknown Journal
Published: Aug 2011
3502 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #23210
Apr 23, 2020Quick Stats
Total Citations:
12
Years Since Retraction:
4.7 years
Open Access:
Yes
Last Checked:
Jul 24, 2025